Ambulero

Ambulero is a spin-out of the University of Miami advancing new AAV cell & gene therapies to treat severe vascular diseases where amputation is a care option

  • Stage Product In Development
  • Industry Biotechnology
  • Location Miami, FL, USA
  • Currency USD
  • Founded November 2019
  • Employees 6
  • Incorporation Type C-corp
  • Website ambulero.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free